Comparing objective wakefulness and vigilance tests to on-the-road driving performance in narcolepsy and idiopathic hypersomnia.


Journal

Journal of sleep research
ISSN: 1365-2869
Titre abrégé: J Sleep Res
Pays: England
ID NLM: 9214441

Informations de publication

Date de publication:
06 2022
Historique:
revised: 26 10 2021
received: 19 08 2021
accepted: 27 10 2021
pubmed: 11 11 2021
medline: 6 5 2022
entrez: 10 11 2021
Statut: ppublish

Résumé

Patients with narcolepsy or idiopathic hypersomnia (IH) are at increased risk of driving accidents. Both excessive daytime sleepiness, i.e. unwanted sleep episodes during the day, and disturbed vigilance are core features of these disorders. We tested on-the-road driving performance of patients with narcolepsy or IH coming in for a routine driving fitness evaluation and examined: (1) correlations between driving performance and the Maintenance of Wakefulness Test (MWT), Sustained Attention to Response Task (SART) and Psychomotor Vigilance Test (PVT) as objective tests; (2) the predictive power of the MWT and SART for increased risk of impaired driving; (3) the best set of objective predictors for increased risk of impaired driving. Participants were 44 patients (aged 18-75 years) with narcolepsy type 1 (NT1), type 2 (NT2) or IH. They completed the MWT, SART, PVT, a subjective sleepiness questionnaire, and a standardised on-the-road driving test. The standard deviation of the lateral position (SDLP) was used as outcome measure of driving performance. The MWT had low correlation with the SDLP (ρ = -0.41 to -0.49, p < 0.01). The SART and PVT had low correlations with SDLP (ρ = 0.30 and ρ = 0.39, respectively, both p < 0.05). The predictive power of MWT for an increased risk of impaired driving was significant, but low (area under the curve = 0.273, p = 0.012), and non-significant for SART. We conclude that in our present group, none of the tests had adequate ability to predict impaired driving, questioning their use for clinical driving fitness evaluation in narcolepsy and IH. Real-time monitoring of sleepiness while driving seems more promising in these patients.

Identifiants

pubmed: 34755413
doi: 10.1111/jsr.13518
pmc: PMC9286536
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13518

Informations de copyright

© 2021 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.

Références

Int J Psychophysiol. 2013 Aug;89(2):195-202
pubmed: 23727627
Lancet Neurol. 2013 Nov;12(11):1068-75
pubmed: 24107292
J Clin Neurophysiol. 2006 Feb;23(1):39-49
pubmed: 16514350
J Clin Sleep Med. 2005 Oct 15;1(4):386-90
pubmed: 17564407
J Clin Exp Neuropsychol. 2014;36(10):1055-65
pubmed: 25494633
Sleep. 2015 Jul 01;38(7):1051-8
pubmed: 25902810
PLoS One. 2015 Feb 10;10(2):e0117045
pubmed: 25668292
Sleep Med. 2019 Mar;55:1-5
pubmed: 30735912
Sleep. 2007 Mar;30(3):331-42
pubmed: 17425230
Psychopharmacology (Berl). 2017 Mar;234(5):837-844
pubmed: 28070617
Neuropsychologia. 1997 Jun;35(6):747-58
pubmed: 9204482
Sleep. 2005 Jan;28(1):113-21
pubmed: 15700727
Electroencephalogr Clin Neurophysiol. 1997 Nov;103(5):554-62
pubmed: 9402886
Electroencephalogr Clin Neurophysiol. 1982 Jun;53(6):658-61
pubmed: 6177511
Hum Psychopharmacol. 2021 Jul;36(4):e2778
pubmed: 33547849
J Sleep Res. 2012 Aug;21(4):390-5
pubmed: 22098127
J Sleep Res. 2022 Jun;31(3):e13518
pubmed: 34755413
Traffic Inj Prev. 2021;22(2):120-126
pubmed: 33543997
Int J Gen Med. 2011;4:359-71
pubmed: 21625472
Sleep. 2011 May 01;34(5):581-91
pubmed: 21532951
Sleep. 2006 Feb;29(2):187-91
pubmed: 16494086
Sleep Med. 2010 Dec;11(10):973-9
pubmed: 20961809
J Sleep Res. 1996 Jun;5(2):128-34
pubmed: 8795814
Psychopharmacology (Berl). 2020 Mar;237(3):877-886
pubmed: 31897572
Ann Neurol. 2008 Oct;64(4):410-6
pubmed: 18688799
Trends Pharmacol Sci. 2017 Apr;38(4):319-321
pubmed: 28283199
J Sleep Res. 2015 Oct;24(5):566-75
pubmed: 25913575
Br J Clin Pharmacol. 1984;18 Suppl 1:121S-129S
pubmed: 6525328
Sleep. 2007 Mar;30(3):327-30
pubmed: 17425229
Psychopharmacology (Berl). 2014 Jun;231(12):2435-47
pubmed: 24408210
J Clin Sleep Med. 2014 Sep 15;10(9):1019-24
pubmed: 25142762
Ther Clin Risk Manag. 2020 Nov 12;16:1099-1108
pubmed: 33209031
Sleep. 2009 Mar;32(3):382-91
pubmed: 19294958
Accid Anal Prev. 2001 Jan;33(1):31-41
pubmed: 11189120
Sleep Med. 2021 Jan;77:249-255
pubmed: 32778442
Sleep. 2014 Mar 01;37(3):483-7
pubmed: 24587570
Int J Neurosci. 1990 May;52(1-2):29-37
pubmed: 2265922
Sleep Med. 2015 Aug;16(8):994-8
pubmed: 26100444

Auteurs

Denise Bijlenga (D)

Sleep-Wake Centre, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.
Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands.

Bram Urbanus (B)

Sleep-Wake Centre, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.

Nick N J J M van der Sluiszen (NNJJM)

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Sebastiaan Overeem (S)

Centre for Sleep Medicine, Kempenhaeghe, Heeze, the Netherlands.
Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.

Jan G Ramaekers (JG)

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Annemiek Vermeeren (A)

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Gert Jan Lammers (GJ)

Sleep-Wake Centre, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.
Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH